OpenEden: All team and advisor tokens will remain locked for another 9 months, with the unlocking period also extended accordingly.

The latest data from Meta Platforms, Inc. shows a slight decline in the company's average daily active users for the quarter.

Everspin Technologies Inc, a leading company in magnetoresistive random-access memory technology, recently announced that it has signed a new $40 million cooperation agreement with a major U.S. prime contractor.

MGM Resorts International reports Q1 net revenue of $4.45 billion, estimated at $4.37 billion

Biopharmaceutical company Alector Inc. announced that it will discontinue its Phase II PROGRESS-AD clinical trial of its candidate drug Nivisnebart (development code AL101/GSK4527226) for the treatment of early-stage Alzheimer's disease.